0001493152-23-008364.txt : 20230321 0001493152-23-008364.hdr.sgml : 20230321 20230321160514 ACCESSION NUMBER: 0001493152-23-008364 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230315 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20230321 DATE AS OF CHANGE: 20230321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PURE BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001006028 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 330530289 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14468 FILM NUMBER: 23749752 BUSINESS ADDRESS: STREET 1: 9669 HERMOSA AVENUE CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 619-596-8600 MAIL ADDRESS: STREET 1: 9669 HERMOSA AVENUE CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCE DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCES DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES DATE OF NAME CHANGE: 19960122 8-K 1 form8-k.htm
0001006028 false 0001006028 2023-03-15 2023-03-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 15, 2023

 

PURE BIOSCIENCE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-14468   33-0530289

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

9669 Hermosa Avenue

Rancho Cucamonga, California

  91730
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (619) 596-8600

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

President and Chief Executive Officer Transition

 

On March 15, 2023 (the “Effective Date”), Tom Y. Lee, the President, Chief Executive Officer and member of the Board of Directors (the “Board”) of Pure Bioscience, Inc. (the “Company”), resigned as the Company’s President and Chief Executive Officer, effective as of the Effective Date. Mr. Lee will continue to serve as a member of the Board.

 

Additionally, the Board appointed Robert Bartlett, a member of the Board, as the Company’s President and Chief Executive Officer, effective as of the Effective Date. In connection with his appointment as the Company’s President and Chief Executive Officer, Mr. Bartlett transitioned off the audit committee of the Board (the “Audit Committee”) and the compensation committee of the Board (the “Compensation Committee”), each effective as of the Effective Date. Mr. Bartlett will continue to serve as a member of the Board. As of the Effective Date, Mr. Bartlett will no longer receive compensation under our non-employee director compensation program.

 

Mr. Bartlett, 78, has served as a member of the Board since February 2023. Mr. Bartlett retired in 2006 as Chairman of the Board of Advanced Marketing Services, a major distributor of books and media to warehouse clubs worldwide. Since 1995, he has been the founder and Managing Director of Combined Resources International, a manufacturer and distributor of picture frames, cork erase boards, and children’s furniture to warehouse clubs in the United States and Canada. From 1993 to 1995, he served as Vice President, Divisional Manager at Anderson Chamberlain, Inc., an in-house general merchandise and food broker for Costco’s warehouse clubs worldwide. From 1990 to 1993, he served as Senior Vice President, Operations, Merchandising, Traffic and Distribution with Source Club, Inc., a division of Meijer Stores. From 1989 to 1990, he served as Executive Vice President Merchandising, Operations, Traffic and Distribution with The Wholesale Club, Inc. until it was sold to Walmart in 1990. Prior to that, from 1981 to 1989, he was Executive Vice President, Merchandising, Traffic and Distribution at The Price Company, Inc., the first membership warehouse club in the United States, which later merged with Costco. He served in the United States Army after being drafted in 1965. He served as an artillery surveyor/training non-commissioned officer for an artillery battalion of the 7th Army in Europe, after which he was honorably discharged at the rank of Sergeant (E-5) in 1967. After discharge, he attended junior college under the GI Bill.

 

The Company entered into an employment agreement with Mr. Bartlett in connection with his appointment as President and Chief Executive Officer (the “Employment Agreement”). The Employment Agreement provides that Mr. Bartlett will receive a base salary of $300,000 per year and a sign-on bonus of $17,500. Additionally, pursuant to the terms of the Employment Agreement, the Compensation Committee will award Mr. Bartlett an option to purchase 500,000 shares of the Company’s common stock (such stock, the “Common Stock” such option, the “Bartlett Option”). The Bartlett Option will vest over time based on Mr. Bartlett’s continuous service as follows: 25% of the shares of Common Stock shall vest on a quarterly basis following the date of grant of the Bartlett Option such that the Bartlett Option shall fully vest on the one-year anniversary of grant. The exercise price per share of the Bartlett Option will be equal to the fair market value of the Common Stock on the date of grant. The Company intends to grant Mr. Bartlett’s equity awards under the Company’s 2017 Equity Incentive Plan. Mr. Bartlett will be subject to customary indemnification provisions.

 

There are no family relationships between Mr. Bartlett and any of the Company’s directors or executive officers and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

Chief Operating Officer Transition

 

Additionally, Tom Myers, the Company’s Chief Operating Officer and member of the Board, resigned as the Company’s Chief Operating Officer in connection with his transition to the Company’s Executive Vice President, Technology and Development, each effective as of the Effective Date. Mr. Myers will continue to serve as a member of the Board.

 

Board Member Resignation

 

On March 19, 2023, Kristin A. Taylor delivered notice to the Board of her resignation from the Board, effective March 19, 2023. Ms. Taylor also resigned her membership on the Audit Committee and the Compensation Committee. The resignation is not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

 


 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PURE BIOSCIENCE, INC.
     
Dated: March 21, 2023 By: /s/ Robert Bartlett
    Robert Bartlett
   

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 

EX-101.SCH 2 pure-20230315.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 pure-20230315_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Information, Former Legal or Registered Name EX-101.PRE 4 pure-20230315_pre.xml XBRL PRESENTATION FILE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
Mar. 15, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 15, 2023
Entity File Number 001-14468
Entity Registrant Name PURE BIOSCIENCE, INC.
Entity Central Index Key 0001006028
Entity Tax Identification Number 33-0530289
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 9669 Hermosa Avenue
Entity Address, City or Town Rancho Cucamonga
Entity Address, State or Province CA
Entity Address, Postal Zip Code 91730
City Area Code (619)
Local Phone Number 596-8600
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Information, Former Legal or Registered Name Not applicable
XML 6 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001006028 2023-03-15 2023-03-15 iso4217:USD shares iso4217:USD shares 0001006028 false 8-K 2023-03-15 PURE BIOSCIENCE, INC. DE 001-14468 33-0530289 9669 Hermosa Avenue Rancho Cucamonga CA 91730 (619) 596-8600 Not applicable false false false false false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( *: =58'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "F@'56.W"A*>X K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M2L0P$(=?17)O)VU1)'1[43PI""XHWD(RNQML_I",M/OVIG&WB^@#>,S,+]]\ M ].K()2/^!Q]P$@&T]5L1Y>$"AMV( H"(*D#6IGJG'"YN?/12LK/N(<@U8?< M([2QAPM@@1%&F[X+J%=BJ?Z)+1U@I^2NI++.S3P]O3X4M:MC$LD MG<+\*QE!QX ;=I[\VMW=;Q_8T/*VJWA7M621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M *: =5:&[RZ$&P0 ',/ 8 >&PO=V]R:W-H965T&UL MC9=M;^(X$,??]U-86>ET)[7- P^%'B#1E-ZB[5)$N[?2G>Z%20Q8F]A9VX'V MV]\XT(3=#1/ZHMB)YY]?QI,9SV GU3>]8NALC,EN75='&Y92?2TS M)N#.2JJ4&IBJM:LSQ6A<&*6)&WA>UTTI%\YH4%R;J]% YB;A@LT5T7F:4O5V MQQ*Y&SJ^\WYAP=<;8R^XHT%&U^R9F2_97,',+55BGC*AN11$L=70&?NW=T%@ M#8H5?W.VTT=C8E]E*>4W.YG&0\>S1"QAD;$2%'ZV+&1)8I6 X_M!U"F?:0V/ MQ^_J#\7+P\LLJ6:A3+[RV&R&3L\A,5O1/#$+N?O(#B_4L7J13'3QG^SV:SN! M0Z)<&YD>C($@Y6+_2U\/CC@R"-HG#(*#0>$(=_^@@O*>&CH:*+DCRJX&-3LH M7K6P!C@N[*X\&P5W.=B942BW3 U< U+V@AL=S.[V9L$)L\]471._#V*YIHAG!T2H[.>)Y_Y;?;W1["N5?+US^$+83443,A4Q>R6?V%L=(:[D@=N@$G@!YK9^ MB=4_!^N%OI)I#&Q\Q2-:9/'3FXHKMEI77J<%='T$S_>JK.F= S@5D5295 7; M)7DV\!40J4@H1)U)/A MDOUNMW]!X.\C4ZG4E(RW3.184O&K$N"C&?P7W-#.P)DOY5K^NASJG*A(_G]Z^*&\,$N"9-6QEO%DN7/ZZZ>S;"=I=67=A['-HN6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZF MTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,7 M8&F? KP(&K XU7=>&18/ MQA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B< M45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^, M%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL> M]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PEY7>>9 ]IV03NA1.XJR MY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD\%G'!QR>(W?#$T%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/ MAG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+ MV.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0 MIA@"IQ%', ; 4/2='@//GL?)=-[*CG_5U/\!%!+ P04 " "F@'56EXJ[ M', 3 @ "P %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6 M!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV M)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(= MI7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( M *: =5:JQ"(6,P$ "(" / >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5 M*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)>]I31=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y M&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C% MB/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\ M@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'! M=09#K+&))@G60VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV M4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04 " "F@'56)!Z; MHJT #X 0 &@ 'AL+U]R96QS+W=O[IFB MG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6 M<%H@XLD@;6E6?;!/3K3G>1,)KM\,<'AT_@%02P,$% @ IH!U M5F60>9(9 0 SP, !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P$(6O M$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1 ML.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3K MU3.T.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY8 M4(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F," MJ;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R M]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]> M?P%02P$"% ,4 " "F@'56!T%-8H$ "Q $ @ $ M 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 ( *: =58[<*$I[@ "L" M 1 " :\ !D;V-0&UL4$L! A0#% @ IH!U5H;O+H0;! 7!E&UL4$L%!@ ) - D /@( +(3 $! end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 20 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://purebio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm pure-20230315.xsd pure-20230315_lab.xml pure-20230315_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 20 }, "contextCount": 1, "dts": { "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "pure-20230315_lab.xml" ] }, "presentationLink": { "local": [ "pure-20230315_pre.xml" ] }, "schema": { "local": [ "pure-20230315.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 60, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 20, "memberCustom": 0, "memberStandard": 0, "nsprefix": "PURE", "nsuri": "http://purebio.com/20230315", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-03-15to2023-03-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://purebio.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-03-15to2023-03-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://purebio.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0001493152-23-008364-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-008364-xbrl.zip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end